Evidence map›Paper›PMID 38993719›Full record

ArticleClinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology2024

A case of long-term survival of SADDAN treated with growth hormone for marked short stature.

Junko Kanno, Yu Katata, Sayaka Kawashima, Hirohito Shima, Chisumi Sogi, Ikumi Umeki, Dai Suzuki, Hasumi Tomita, Miki Kamimura, Akiko Saito-Hakoda and 3 more

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Evidence-based classification of genes implicated in skeletal disorders using the ClinGen curation framework.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Junko KannoDepartment of Pediatrics, Tohoku University Hospital, Sendai, Japan.
Yu KatataDepartment of Pediatrics, Tohoku University Hospital, Sendai, Japan.
Sayaka KawashimaDepartment of Pediatrics, Tohoku University Hospital, Sendai, Japan.
Hirohito ShimaDepartment of Pediatrics, Tohoku University Hospital, Sendai, Japan.
Chisumi SogiDepartment of Pediatrics, Tohoku University Hospital, Sendai, Japan.
Ikumi UmekiDepartment of Pediatrics, Tohoku University Hospital, Sendai, Japan.
Dai SuzukiDepartment of Pediatrics, Tohoku University Hospital, Sendai, Japan.
Hasumi TomitaDepartment of Gynecology and Obstetrics, Tohoku University Hospital, Sendai, Japan.
Miki KamimuraDepartment of Pediatrics, Tohoku University Hospital, Sendai, Japan.
Akiko Saito-HakodaDepartment of Pediatrics, Tohoku University Hospital, Sendai, Japan.
Ikuma FujiwaraDepartment of Pediatrics, Tohoku University Hospital, Sendai, Japan.
Takushi HanitaDepartment of Pediatrics, Tohoku University Hospital, Sendai, Japan.
Atsuo KikuchiDepartment of Pediatrics, Tohoku University Hospital, Sendai, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Severe achondroplasia with developmental delay and acanthosis nigricans (SADDAN) is a bone dysplasia caused by a pathogenic variant of fibroblast growth factor receptor 3 (

Indexed as

FGFR3GHlong-term survivalSADDAN

Identifiers

PMID38993719
PMCPMC11234192

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.